oalib

Publish in OALib Journal

ISSN: 2333-9721

APC: Only $99

Submit

Any time

2018 ( 3 )

2017 ( 3 )

2016 ( 2 )

2015 ( 91 )

Custom range...

Search Results: 1 - 10 of 1748 matches for " KG Bennett "
All listed articles are free for downloading (OA Articles)
Page 1 /1748
Display every page Item
Gorlin syndrome
JA Geel, KG Bennett, JM Rigby, JE Poole
South African Journal of Child Health , 2011,
Abstract: Naevoid basal cell carcinoma syndrome (NBCCS), also known as Gorlin syndrome, is an autosomal dominant syndrome of developmental anomalies associated with an increased risk of malignancies. Patients have multiple lesions, which may be subtle, and the diagnosis can easily be missed, leading to sub-optimal follow-up. Despite its infrequency clinicians may benefit from familiarity with the syndrome, as these patients are hypersensitive to radiation and prone to develop multiple malignancies. Patients can present to paediatricians, oncologists, maxillofacial surgeons, radiation oncologists and dermatologists, and it will be to the benefit of the patient with this syndrome for these specialists to have a working knowledge of this rare but fascinating disorder.
The interface between Nation Interest and Regional Stability: The Nile river and the Riparian states
KG Adar
African Sociological Review / Revue Africaine de Sociologie , 2007,
Abstract:
Kenya's Foreign Policy and geopolitical interests: The case of the Nile River Basin
KG Adar
African Sociological Review / Revue Africaine de Sociologie , 2007,
Abstract:
Role of Stakeholders at Cape Coast PPAG Youth Centre: Deficiencies and Implications.
KG Badu
Edo Journal of Counselling , 2009,
Abstract: The study investigated whether the activities or the roles performed by the various stakeholders at the Cape Coast Planned Parenthood Association of Ghana (PPAG) youth centre impacted positively on the youth behaviour and performance at the centre. The sample comprised 22 teachers, 50 parents and 3 social welfare workers who were supposed to work with the centre. Data was collected with questionnaire and analysed with percentages. The results indicated that apart from the seemingly impressive recommendation role of stakeholders, all the other roles, namely, information, visitation, referral and follow-ups were found to be weak and ineffective and seemed to have little impact on the youth and the programme in general. It is recommended among others that long term educational campaign programmes should be mounted for all stakeholders on a regular and sustainable basis to achieve this desired goal. Key Words: stakeholders, youth, deficiency, quality care delivery, education.
Mipomersen: evidence-based review of its potential in the treatment of homozygous and severe heterozygous familial hypercholesterolemia
Parhofer KG
Core Evidence , 2012, DOI: http://dx.doi.org/10.2147/CE.S25239
Abstract: mersen: evidence-based review of its potential in the treatment of homozygous and severe heterozygous familial hypercholesterolemia Review (2328) Total Article Views Authors: Parhofer KG Published Date May 2012 Volume 2012:7 Pages 29 - 38 DOI: http://dx.doi.org/10.2147/CE.S25239 Received: 19 March 2012 Accepted: 21 April 2012 Published: 31 May 2012 Klaus G Parhofer Medical Department II, Grosshadern, University Munich, Munich, Germany Abstract: Familial hypercholesterolemia (FH) is an autosomal-dominant inherited disease with a prevalence of one in 500 (heterozygous) to one in 1,000,000 (homozygous). Mutations of the low-density lipoprotein (LDL) receptor gene, the apolipoprotein B100 gene, or the PCSK9 gene may be responsible for the disease. The resulting LDL hypercholesterolemia results in premature atherosclerosis as early as childhood (homozygous FH) or in adulthood (heterozygous FH). Current treatment modalities include lifestyle modification, combination drug therapy (statin-based), and apheresis. Mipomersen is an antisense oligonucleotide which inhibits apolipoprotein B production independent of LDL receptor function and thus works in homozygous FH, heterozygous FH, and other forms of hypercholesterolemia. Mipomersen is given 200 mg/week subcutaneously. Phase III studies indicate that the LDL cholesterol concentration can be reduced by 25%–47%, lipoprotein(a) levels by 20%–40%, and triglyceride concentrations by approximately 10%. In general, mipomersen has no effect on high-density lipoprotein cholesterol concentrations. Although there is considerable interindividual variability, the observed lipid effects are largely independent of age, gender, concomitant statin therapy, and underlying dyslipoproteinemia. The most common side effects are injection site reactions (70%–100%), flu-like symptoms (29%–46%), and elevated transaminases associated with an increased liver fat content (6%–15%). Mipomersen may be an interesting addon drug in patients with heterozygous or homozygous FH not reaching treatment goals, either because baseline values are very high or because high-dose statins are not tolerated.
Efficacy and safety of the phytotherapeutic drug Canephron N in prevention and treatment of urogenital and gestational disease: review of clinical experience in Eastern Europe and Central Asia
Naber KG
Research and Reports in Urology , 2013, DOI: http://dx.doi.org/10.2147/RRU.S39288
Abstract: acy and safety of the phytotherapeutic drug Canephron N in prevention and treatment of urogenital and gestational disease: review of clinical experience in Eastern Europe and Central Asia Review (461) Total Article Views Authors: Naber KG Published Date February 2013 Volume 2013:5 Pages 39 - 46 DOI: http://dx.doi.org/10.2147/RRU.S39288 Received: 17 October 2012 Accepted: 11 November 2012 Published: 05 February 2013 Kurt G Naber Technical University, Munich, Germany Abstract: This review evaluates 17 clinical studies from 18 selected publications concerning the safety, tolerability, and additional effects of the phytotherapeutic drug, Canephron N (CAN, containing the medicinal plants, Centaurium erythraea, Levisticum officinale, and Rosmarinus officinalis) as standard therapy in various clinical settings. Its role in the prophylaxis and treatment of urinary tract infections in adults and in children, therapy and prophylaxis in adult patients with renal stones, treatment and prevention of urinary tract infections and other gestational diseases in pregnancy, and also its safety and tolerability. The dosage was as recommended and over a varying duration. Overall, CAN was shown to be effective in the treatment and prophylaxis of UTI compared with standard therapy, both in adults and children, and there was a reduced number of relapses. Children undergoing surgical correction of vesicoureteral reflux benefited from a prophylactic course of CAN. Ten-day add on therapy increased the rate of spontaneous elimination of kidney stones compared with standard therapy alone and may also have had a positive effect on stone prevention. Pregnant women showed earlier relief of symptoms and normalization of pyuria on additional treatment with the herbal combination. Only one adverse effect was reported (skin rash) in the 3115 patients included in this review. No teratogenic, embryotoxic, or fetotoxic effects, or negative interference with the psychological development or health of children born of mothers treated with the drug were reported. Because some of the studies were not well designed, their statistical significance remains unclear.
Letter to the Editor
Naber KG
International Journal of General Medicine , 2011, DOI: http://dx.doi.org/10.2147/IJGM.S25990
Abstract: Letter to the Editor Letter (2003) Total Article Views Authors: Naber KG Published Date November 2011 Volume 2011:4 Pages 755 - 757 DOI: http://dx.doi.org/10.2147/IJGM.S25990 Kurt G Naber Technical University of Munich, Munich, Germany Minardi et al1 have described well-established risk factors for recurrent urinary tract infection (UTI) and have emphasized the importance of a clear communication with the patient in order to find out behavior at risk, channel right hygiene recommendations, and suggest necessary changes in life habits to prevent acute UTI episodes. There is general agreement that behavioral modifications and counseling should be attempted first to reduce the rate of acute UTI episodes and their associated discomfort. Post to: Cannotea Citeulike Del.icio.us Facebook LinkedIn Twitter Readers of this article also read: Outcome predictors for treatment success with 5% lidocaine medicated plaster in low back pain with neuropathic components and neuropathic pain after surgical and nonsurgical trauma Amino acid management of Parkinson’s disease: a case study Endometrial safety of an oral contraceptive containing estradiol valerate and dienogest Evaluation of a local ICU sedation guideline on goal-directed administration of sedatives and analgesics Enzyme replacement therapy for pancreatic insufficiency: present and future Comparison of risk factors between preterm and term infants hospitalized for severe respiratory syncytial virus in the Russian Federation Pilot study of the efficacy and safety of lettuce seed oil in patients with sleep disorders Relation between ABO blood groups and Helicobacter pylori infection in symptomatic patients Effect of Helicobacter pylori infection on pregnancy rates and early pregnancy loss after intracytoplasmic sperm injection Cumulative clinical experience from over a decade of use of levofloxacin in community-acquired pneumonia: critical appraisal and role in therapy
Letter to the Editor
Naber KG
International Journal of General Medicine , 2011,
Abstract: Kurt G NaberTechnical University of Munich, Munich, GermanyMinardi et al1 have described well-established risk factors for recurrent urinary tract infection (UTI) and have emphasized the importance of a clear communication with the patient in order to find out behavior at risk, channel right hygiene recommendations, and suggest necessary changes in life habits to prevent acute UTI episodes. There is general agreement that behavioral modifications and counseling should be attempted first to reduce the rate of acute UTI episodes and their associated discomfort.
Efficacy and safety of the phytotherapeutic drug Canephron N in prevention and treatment of urogenital and gestational disease: review of clinical experience in Eastern Europe and Central Asia
Naber KG
Research and Reports in Urology , 2013,
Abstract: CorrigendumNaber KG. Research and Reports in Urology. 2013;5:39–46.Page 42, a new first sentence should be added to the Conclusion section as follows:"The three months administration of the herbal remedy for prevention of acute pyelonephritis in children was as effective as the prophylaxis using nitrofurantoin."On page 42, left column, in the Prevention and treatment of renal stone disease in adults section, the number of patients should be amended as follows:"In the two publications by Chernenko et al, a total of 110 patients with urolithiasis were treated for 8 weeks, and 25 patients served as control."Also on page 42, right column, upper paragraph, instead of "One month after cessation of treatment…", this should say "After one month of treatment…".Read the original article
Efficacy and safety of the phytotherapeutic drug Canephron® N in prevention and treatment of urogenital and gestational disease: review of clinical experience in Eastern Europe and Central Asia
Naber KG
Research and Reports in Urology , 2013,
Abstract: Kurt G NaberTechnical University, Munich, GermanyAbstract: This review evaluates 17 clinical studies from 18 selected publications concerning the safety, tolerability, and additional effects of the phytotherapeutic drug, Canephron N (CAN, containing the medicinal plants, Centaurium erythraea, Levisticum officinale, and Rosmarinus officinalis) as standard therapy in various clinical settings. Its role in the prophylaxis and treatment of urinary tract infections in adults and in children, therapy and prophylaxis in adult patients with renal stones, treatment and prevention of urinary tract infections and other gestational diseases in pregnancy, and also its safety and tolerability. The dosage was as recommended and over a varying duration. Overall, CAN was shown to be effective in the treatment and prophylaxis of UTI compared with standard therapy, both in adults and children, and there was a reduced number of relapses. Children undergoing surgical correction of vesicoureteral reflux benefited from a prophylactic course of CAN. Ten-day add on therapy increased the rate of spontaneous elimination of kidney stones compared with standard therapy alone and may also have had a positive effect on stone prevention. Pregnant women showed earlier relief of symptoms and normalization of pyuria on additional treatment with the herbal combination. Only one adverse effect was reported (skin rash) in the 3115 patients included in this review. No teratogenic, embryotoxic, or fetotoxic effects, or negative interference with the psychological development or health of children born of mothers treated with the drug were reported. Because some of the studies were not well designed, their statistical significance remains unclear.Keywords: Canephron N, herbal remedy, urogenital disease, gestational disease
Page 1 /1748
Display every page Item


Home
Copyright © 2008-2017 Open Access Library. All rights reserved.